Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease
- PMID: 21252206
- DOI: 10.1093/hmg/ddr019
Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease
Abstract
Gaucher disease (GD), the most common lysosomal storage disorder, is caused by a deficiency in the lysosomal enzyme glucocerebrosidase (GlcCerase), which results in intracellular accumulation of glucosylceramide (GlcCer). The rare neuronopathic forms of GD are characterized by profound neurological impairment and neuronal cell death, but little is known about the neuropathological changes that underlie these events. We now systematically examine the onset and progression of various neuropathological changes (including microglial activation, astrogliosis and neuron loss) in a mouse model of neuronopathic GD, and document the brain areas that are first affected, which may reflect vulnerability of these areas to GlcCerase deficiency. We also identify neuropathological changes in several brain areas and pathways, such as the substantia nigra reticulata, reticulotegmental nucleus of the pons, cochlear nucleus and the somatosensory system, which could be responsible for some of the neurological manifestations of the human disease. In addition, we establish that microglial activation and astrogliosis are spatially and temporally correlated with selective neuron loss.
Similar articles
-
Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.J Clin Invest. 2002 May;109(9):1215-21. doi: 10.1172/JCI14530. J Clin Invest. 2002. PMID: 11994410 Free PMC article.
-
Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.Brain. 2012 Jun;135(Pt 6):1724-35. doi: 10.1093/brain/aws095. Epub 2012 May 7. Brain. 2012. PMID: 22566609
-
No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease.Hum Mol Genet. 2009 Apr 15;18(8):1482-8. doi: 10.1093/hmg/ddp061. Epub 2009 Feb 3. Hum Mol Genet. 2009. PMID: 19193629
-
Neuronal forms of Gaucher disease.Handb Exp Pharmacol. 2013;(216):405-19. doi: 10.1007/978-3-7091-1511-4_20. Handb Exp Pharmacol. 2013. PMID: 23563668 Review.
-
Gaucher disease: complexity in a "simple" disorder.Mol Genet Metab. 2004 Sep-Oct;83(1-2):6-15. doi: 10.1016/j.ymgme.2004.08.015. Mol Genet Metab. 2004. PMID: 15464415 Review.
Cited by
-
GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice.Mol Neurodegener. 2024 Mar 7;19(1):22. doi: 10.1186/s13024-024-00713-z. Mol Neurodegener. 2024. PMID: 38454456 Free PMC article.
-
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery.Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220381. doi: 10.1098/rstb.2022.0381. Epub 2024 Feb 19. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38368939 Free PMC article. Review.
-
A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease.Int J Mol Sci. 2024 Feb 2;25(3):1827. doi: 10.3390/ijms25031827. Int J Mol Sci. 2024. PMID: 38339105 Free PMC article.
-
Autophagic dysfunction and gut microbiota dysbiosis cause chronic immune activation in a Drosophila model of Gaucher disease.PLoS Genet. 2023 Dec 21;19(12):e1011063. doi: 10.1371/journal.pgen.1011063. eCollection 2023 Dec. PLoS Genet. 2023. PMID: 38127816 Free PMC article.
-
Animal Models for the Study of Gaucher Disease.Int J Mol Sci. 2023 Nov 7;24(22):16035. doi: 10.3390/ijms242216035. Int J Mol Sci. 2023. PMID: 38003227 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
